Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300071956Phase 4Recruiting
Phase 4, open-label, single-arm trial of oxycodone in bronchial carcinoma, sponsored by Shengjing Hospital of China Medical University. Primary endpoint: Numeric Rating Scale (NRS) score at cough 2 hours after surgery. Started Apr 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300071956.